Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Choosing the right patients, using proper techniques, and having thorough knowledge are key to preventing and managing dermal filler complications.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Minoxidil solution helps hair regrowth in alopecia areata, with 5% being more effective.

Niosomes are promising for skin drug delivery, offering benefits like improved drug penetration and stability.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Early onset and pustules indicate severe hair follicle inflammation, and while antibiotics help, the condition often worsens after treatment stops.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

PRP more effective than minoxidil 5% for treating alopecia areata.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Both mouse and rat models are effective for testing alopecia areata treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Wounds on the face usually heal with scars, but understanding how some wounds heal without scars could lead to better treatments.

Ice-skating athletes often have skin problems due to cold, infections, and inflammation, needing careful treatment and prevention.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

Hair breakage may be an early sign of a hair loss condition called CCCA in African American women.

Apremilast was not effective in treating moderate-to-severe alopecia areata.